Professor David Price

Chair of Primary Care Respiratory Med

About

Email Address: d.price@abdn.ac.uk
Telephone Number: +44 (0)1224 437237
School/Department: School of Medicine, Medical Sciences and Nutrition

Publications

Page 5 of 34 Results 101 to 125 of 837

Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
2022 - Published
Price, D.
British Thoracic Society Winter Meeting 2022, pp. A54
Contributions to Conferences: Abstracts
- [ONLINE] https://www.brit-thoracic.org.uk/education-and-events/winter-meeting/
- [ONLINE] https://www.brit-thoracic.org.uk/media/456046/bts-winter-meeting-2022-final-programme-thorax-supplement.pdf
S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
2022 - Published
Tse, G., Emmanuel, B., Ariti, C., Bafadhel, M., Papi, A., Carter, V., Zhou, J., Xu, X., Müllerová, H., Price, D., Skinner, D.
Thorax, vol. 77, no. Suppl. 1, pp. A54
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.94
- [ONLINE] https://www.brit-thoracic.org.uk/media/456046/bts-winter-meeting-2022-final-programme-thorax-supplement.pdf
P186 Facilitators to recruiting COPD patients to an adherence intervention trial
2022 - Published
Dickens, A., Halpin, D., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
Thorax, vol. 77, no. Suppl. 1, A182
Contributions to Journals: Abstracts
- [ONLINE] http://thorax.bmj.com/content/77/Suppl_1/A182.1.abstract
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.320
P214 Oral corticosteroid-related healthcare resource utilisation in patients with COPD
2022 - Published
Tse, G., Ariti, C., Bafadhel, M., Papi, A., Carter, V., Zhou, J., Skinner, D., Xu, X., Müllerová, H., Emmanuel, B., Price, D.
Thorax, vol. 77, no. Suppl. 1, pp. A195
Contributions to Journals: Abstracts
- [ONLINE] http://thorax.bmj.com/content/77/Suppl_1/A195.2.abstract
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.346
S117 Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
2022 - Published
Dickens, A., Halpin, D., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
Thorax, vol. 77, no. Suppl. 1, A72
Contributions to Journals: Abstracts
- [ONLINE] http://thorax.bmj.com/content/77/Suppl_1/A72.abstract
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.123
Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy
2022 - Published
Chen, W., Sadatsafavi, M., Tran, T. N., Murray, R. B., Wong, N. C. B., Ali, N., Ariti, C., Gil, E. G., Newell, A. P., Alacqua, M., Al-Ahmad, M., Altraja, H., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A. S., Bourdin, A., Bulathsinhala, L., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Yoo, K. H., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Siyue, M. K., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L. A., Lyu, J., Mahboub, B., Maspero, J. F., Menzies-Gow, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez de Llano, L., Perng, D. W., Peters, M., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Suppli Ulrik, C., Ra, S. W., Eileen, W., Wechsler, M. E., Price, D.
Journal of Asthma and Allergy, vol. 15, no. 15, pp. 1491—1510
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/JAA.S377174
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19342/2/Chen_etal_JAA_Characterization_Of_Patients_VoR.pdf
Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
2022 - Published
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
CHEST 2022, pp. A28-A32
Contributions to Journals: Abstracts
- [ONLINE] https://www.sciencedirect.com/science/article/pii/S0012369222013800
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.020
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/21882/1/Ali_etal_CHEST_Clinical_Outcomes_In_AAM.pdf
Clinical Review: The suggested management pathway for urticaria in primary care
2022 - Published
Ryan, D., Tanno, L. K., Angier, L., Clark, E., Price, D., Zuberbier, T., Maurer, M.
Clinical and Translational Allergy, vol. 12, no. 10, e12195
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1002/clt2.12195
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19302/1/Ryan_etal_CTA_Clinical_Review_The_VoR.pdf
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
2022 - Published
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
CHEST Annual Meeting, pp. A23-A27
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.019
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/23031/1/Ali_etal_CHEST_Clinical_Outcomes_And_AAM.pdf
Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort
2022 - Published
Price, D., Hancock, K., Doan, J., Taher, S. W., Muhwa, C. J., Farouk, H., Beekman, M. J.
npj Primary Care Respiratory Medicine, vol. 32, 37
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1038/s41533-022-00295-7
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19267/1/Price_etal_NPJ_Short_Acting_VoR.pdf
Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs
2022 - Published
Leving, M., van Boven, J. F., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, E. S., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/COPD.S380736
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19228/1/Leving_etal_IJCOPD_Suboptimal_Peak_Inspiratory_VOR.pdf
Oral corticosteroids in asthma and beyond: moving forward
2022 - Published
Shi Kai Chan, J., Murray, R. B., Price, D.
European Respiratory Journal, vol. 60, no. 3, 2200776
Contributions to Journals: Editorials
- [ONLINE] DOI: https://doi.org/10.1183/13993003.00776-2022
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/21673/1/Chan_etal_ERJ_Oral_Corticosteroids_In_AAM.pdf
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
2022 - Published
Chen, S., Miravitlles, M., Rhee, C. K., Pavord, I. D., Jones, R., Carter, V., Emmanuel, B., Alacqua, M., Price, D.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187—2200
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/COPD.S378649
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19154/1/Chen_etal_IJCOPD_Patients_With_Chronic_VoR.pdf
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
2022 - Accepted/In press
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., JacobNara, J. A., JacobNara, J. A., Deniz, Y., Siddiqui, S.
Nexus
Contributions to Conferences: Abstracts
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
2022 - Published
Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H., Heaney, L. G., Carter, V., Chapaneri, J., Tran, T. N., Maslova, E., Price, D.
European Respiratory Society (ERS) International Congress., 4420
Contributions to Journals: Abstracts
- [ONLINE] http://erj.ersjournals.com/content/60/suppl_66/4420.abstract
- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.4420
Over-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III
2022 - Published
Farouk, H., Mattarucco, W. J., Barriga, R. M., Wang, H., Diaz, D., Khattab, A., Gallego, M. P., Zaabi, A. A., Price, D.
European Respiratory Society (ERS) International Congress.
Contributions to Journals: Abstracts
- [ONLINE] http://erj.ersjournals.com/content/60/suppl_66/3434.abstract
- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.3434
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
2022 - Published
Dickens, A., Halpin, D., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., Boven, J. F. V., Mastoridis, P., Mezzi, K., Davis, S., Price, D.
European Respiratory Society (ERS) International Congress., 3402
Contributions to Journals: Abstracts
- [ONLINE] http://erj.ersjournals.com/content/60/suppl_66/3402.abstract
- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.3402
Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study
2022 - Published
Alzaabi, A., Mattarucco, W. J., Barriga, R. M., Wang, H., Diaz, D., Khattab, A., Pacheco Gallego, M., Farouk, H., Price, D.
European Respiratory Society (ERS) International Congress., 3397
Contributions to Journals: Abstracts
- [ONLINE] http://erj.ersjournals.com/content/60/suppl_66/3397.abstract
- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.3397
Mortality Analyses on Systemic Corticosteroid Use: a Long-term Observational Study
2022 - Published
Xu, X., Tran, T. N., Golam, S., Carter, V., Price, D.
BTS Winter Meeting 2021, pp. A7-A8
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1136/thorax-2021-BTSabstracts.11
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/23330/1/Xu_etal_BTS2021_Mortality_Analyses_On_AAM.pdf
- [ONLINE] https://www.brit-thoracic.org.uk/document-library/winter-meetings/winter-meeting-2021/winter-meeting-2021-abstract-programme/
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
2022 - Published
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Eastern Pulmonary Conference 2022
Contributions to Conferences: Abstracts
A pragmatic primary practice approach to using specific IgE in allergy testing in asthma diagnosis, management, and referral
2022 - Published
Demoly, P., Liu, A. H., Rodriguez Del Rio, P., Pedersen, S., Casale, T. B., Price, D.
Journal of Asthma and Allergy, vol. 2022, no. 15, pp. 1069—1080
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/JAA.S362588
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19071/1/Demoly_etal_JAA_A_Pragmatic_Primary_VoR.pdf
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
2022 - Accepted/In press
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
World Allergy Congress 2022
Contributions to Conferences: Abstracts
Correspondence to Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
2022 - Published
Smith, P. K., Lesslar, O., Price, D. B.
Allergy, vol. 77, no. 8, pp. 2571-2573
Contributions to Journals: Letters
- [ONLINE] DOI: https://doi.org/10.1111/all.15281
- [ONLINE] View publication in Scopus
Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid–Dependent Severe Asthma
2022 - Accepted/In press
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
CHEST 2022
Contributions to Conferences: Abstracts
COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry
2022 - Published
Pace, W. D., Brandt, E., Carter, V. A., Chang, K., Edwards, C. L., Evans, A., Fox, C., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W. H., Kruszyk, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
Annals of Family Medicine, vol. 20, no. 4, pp. 319-327
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1370/afm.2829

... 3
4
5
6
7 ...

Show 10 | 25 | 50 | 100 results per page

Update

Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study

S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study

P186 Facilitators to recruiting COPD patients to an adherence intervention trial

P214 Oral corticosteroid-related healthcare resource utilisation in patients with COPD

S117 Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial

Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy

Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study

Clinical Review: The suggested management pathway for urticaria in primary care

Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study

Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort

Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs

Oral corticosteroids in asthma and beyond: moving forward

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

Over-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III

Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial

Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study

Mortality Analyses on Systemic Corticosteroid Use: a Long-term Observational Study

Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

A pragmatic primary practice approach to using specific IgE in allergy testing in asthma diagnosis, management, and referral

Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study

Correspondence to Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid–Dependent Severe Asthma

COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions